Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

MolMed completes €56.2mm IPO on Borsa Italiana

Executive Summary

MolMed SPA (primarily oncology pharmaceuticals) grossed €56.2mm ($82.3mm) in its initial public offering on Borsa Italiana, the Italian stock exchange. It sold 26.1mm shares at €2.15 each, the bottom of its €2.15-2.75 range announced earlier this month.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies